Vertex Pharmaceuticals Incorporated (VRTX) Q3 2015 Earnings Results

Vertex Pharmaceuticals Misses on EPS, Stock Down 0.75%

Vertex Pharmaceuticals reported a loss per share of $-0.13, which was better than expected, but the lack of revenue data leaves uncertainty. The stock reacted negatively, declining by 0.75%. Investors may be cautious due to the absence of guidance and further details from the earnings call.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.13	N/A	+78.33%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Vertex Pharmaceuticals Misses on EPS, Stock Down 0.75%

Key numbers

Management commentary

Vertex Pharmaceuticals Incorporated

More earnings this week

Vertex Pharmaceuticals Misses on EPS, Stock Down 0.75%

Key numbers

Management commentary